A Randomized Trial of Zoledronic Acid to Prevent Bone Loss in the First Year after Kidney Transplantation

BACKGROUND: Bone and mineral disorders commonly affect kidney transplant (KTx) recipients and have been associated with a high risk of fracture. Bisphosphonates may prevent or treat bone loss in such patients, but there is concern that these drugs might induce adynamic bone disease (ABD). METHODS: I...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Am Soc Nephrol
Main Authors: Marques, Igor Denizarde Bacelar, Araújo, Maria Júlia Correia Lima Nepomuceno, Graciolli, Fabiana Giorgetti, dos Reis, Luciene Machado, Pereira, Rosa Maria R., Alvarenga, Jackeline C., Custódio, Melani Ribeiro, Jorgetti, Vanda, Elias, Rosilene Motta, Moysés, Rosa Maria Affonso, David-Neto, Elias
Formato: Artigo
Idioma:Inglês
Publicado: American Society of Nephrology 2019
Assuntos:
Clinical Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6362629/
https://ncbi.nlm.nih.gov/pubmed/30606784
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2018060656
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares